Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking

Most patients with cystic fibrosis (CF) have a single codon deletion (ΔF508) in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that impairs assembly of the multidomain glycoprotein. The mutant protein escapes endoplasmic reticulum (ER) quality control at low temperature, but is rapidly cleared from the distal secretory pathway and degraded in lysosomes. CF cells accumulate free cholesterol similar to Niemann-Pick disease type C cells. We show that this lipid alteration is caused by the presence of misassembled mutant CFTR proteins, including ΔF508, in the distal secretory pathway rather than the absence of functional CFTR. By contrast, cholesterol distribution is not changed by either D572N CFTR, which does not mature even at low temperature, or G551D, which is processed normally but is inactive. On expression of the ΔF508 mutant, cholesterol and glycosphingolipids accumulate in punctate endosomal structures and cholesterol esters are reduced, indicating a block in the translocation of cholesterol to the ER for esterification. This is overcome by Rab9 overexpression, resulting in clearance of accumulating intracellular cholesterol. Similar but less pronounced alterations in intracellular cholesterol distribution are observed on expression of a temperature-rescued mutant variant of the related ATP-binding cassette (ABC) protein multidrug resistance-associated protein 1 (MRP1). Thus, on escape from ER quality control, misassembled mutants of CFTR and MRP1 impair lipid homeostasis in endocytic compartments.

• Publication year

  2006

• Venue

  Journal of Cell Science

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1242/jcs.03350PMID 17213331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes?

  2006cited by this paper
• MLN64 and MENTHO, two mediators of endosomal cholesterol transport.

  2006cited by this paper
• Mechanism of Cholesterol Transfer from the Niemann-Pick Type C2 Protein to Model Membranes Supports a Role in Lysosomal Cholesterol Transport*♦

  2006cited by this paper
• Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1/Vps4

  2006cited by this paper
• Dynamin is Involved in Endolysosomal Cholesterol Delivery to the Endoplasmic Reticulum: Role in Cholesterol Homeostasis

  2006cited by this paper
• Cholesterol sensing, trafficking, and esterification.

  2006cited by this paper
• The genetics of ATP-binding cassette transporters.

  2005cited by this paper
• Role of cholesterol and lipid organization in disease

  2005cited by this paper
• Protein transduction of Rab9 in Niemann‐Pick C cells reduces cholesterol storage

  2005cited by this paper
• Use of fluorescent sphingolipid analogs to study lipid transport along the endocytic pathway.

  2005cited by this paper
• Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency

  2005influential reference
• Lipid and cholesterol trafficking in NPC.

  2004cited by this paper
• Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic.

  2004cited by this paper
• Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.

  2004cited by this paper
• Mistargeted MRPΔF728 mutant is rescued by intracellular GSH

  2004cited by this paper
• Association of cystic fibrosis with abnormalities in fatty acid metabolism.

  2004cited by this paper
• Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.

  2004influential reference
• Localization of Cystic Fibrosis Transmembrane Conductance Regulator to Lipid Rafts of Epithelial Cells Is Required for Pseudomonas aeruginosa-Induced Cellular Activation 1

  2004cited by this paper
• Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts.

  2004influential reference
• Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling.

  2004cited by this paper
• Misfolding diverts CFTR from recycling to degradation

  2004influential reference
• Caveolins and membrane cholesterol.

  2004cited by this paper
• Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C.

  2004influential reference
• Mistargeted MRPdeltaF728 mutant is rescued by intracellular GSH.

  2004cited by this paper
• CHAPTER 19 – MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1)

  2003cited by this paper
• Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage*

  2003cited by this paper
• CHAPTER 29 – THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (ABCC7)

  2003cited by this paper
• Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

  2002influential reference
• Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

  2002influential reference
• Characterization of a cis-Gol Matrix Protein , GM 130

  2002cited by this paper
• Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.

  2002cited by this paper
• Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis

  2002influential reference
• Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments*

  2001cited by this paper
• Localization of Sequences within the C-terminal Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Which Impact Maturation and Stability*

  2001cited by this paper
• Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.

  2001cited by this paper
• The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.

  2000cited by this paper
• Jamming the endosomal system: lipid rafts and lysosomal storage diseases.

  2000cited by this paper
• Allosteric Interactions between the Two Non-equivalent Nucleotide Binding Domains of Multidrug Resistance Protein MRP1*

  2000influential reference
• Identification of HE1 as the second gene of Niemann-Pick C disease.

  2000influential reference
• Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator.

  1999cited by this paper
• C-terminal Truncations Destabilize the Cystic Fibrosis Transmembrane Conductance Regulator without Impairing Its Biogenesis

  1999cited by this paper
• Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases

  1999cited by this paper
• Physiological basis of cystic fibrosis: a historical perspective.

  1999cited by this paper
• Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome

  1998cited by this paper
• Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation.

  1997cited by this paper
• ATPase Activity of Purified Multidrug Resistance-associated Protein*

  1997cited by this paper
• Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.

  1997cited by this paper
• cAMP-dependent Protein Kinase-mediated Phosphorylation of Cystic Fibrosis Transmembrane Conductance Regulator Residue Ser-753 and Its Role in Channel Activation (*)

  1995cited by this paper
• Characterization of a cis-Golgi matrix protein, GM130

  1995cited by this paper
• Internalization and sorting of a fluorescent analogue of glucosylceramide to the Golgi apparatus of human skin fibroblasts: utilization of endocytic and nonendocytic transport mechanisms

  1994cited by this paper
• Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites.

  1993cited by this paper
• The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells.

  1993cited by this paper
• Molecular biology of cystic fibrosis.

  1993cited by this paper
• Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa.

  1993cited by this paper
• The molecular biology of cystic fibrosis.

  1993cited by this paper
• Type C Niemann-Pick disease. Detection and quantification of cholesterol-accumulating cells in bone marrow.

  1993cited by this paper
• Lipoprotein abnormalities associated with cholesteryl ester transfer activity in cystic fibrosis patients: the role of essential fatty acid deficiency.

  1993cited by this paper
• Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2

  1991cited by this paper
• [Type C Niemann-Pick disease].

  1991cited by this paper
• A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein

  1990cited by this paper
• Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol.

  1988cited by this paper
• Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts.

  1986cited by this paper

• Characterisation of a primary ciliary dyskinesia model generated from BMI1-transduced basal epithelial cells

  2025cites this paper
• The treatment with Elexacaftor/Tezacaftor/Ivacaftor significantly increases serum bilirubin and decreases blood platelets in children and adolescents with cystic fibrosis homozygous or double heterozygous for the F508del CFTR variant.

  2025cites this paper
• One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes

  2024cites this paper
• Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment

  2024cites this paper
• Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections

  2023cites this paper
• Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs

  2022cites this paper
• Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex

  2022cites this paper
• Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study

  2021cites this paper
• Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis

  2021influential citation
• The bidirectional relationship between CFTR and lipids

  2020cites this paper
• An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line

  2020cites this paper
• Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.

  2020cites this paper
• Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism

  2020cites this paper
• Resveratrol restores intracellular transport in cystic fibrosis epithelial cells.

  2020cites this paper
• Agonists that stimulate secretion promote the recruitment of CFTR into membrane lipid microdomains

  2019cites this paper
• Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.

  2019cites this paper
• An Intriguing Involvement of Mitochondria in Cystic Fibrosis

  2019cites this paper
• Impaired cholesterol metabolism in the mice model of cystic fibrosis. A vicious circle?

  2019cites this paper
• Tuning the solubility of ionophores: glutathione-mediated transport of chloride ions across hydrophobic membranes.

  2019cites this paper
• Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease

  2017cites this paper
• CRISPR/Cas9-Mediated Three Nucleotide Insertion Corrects a Deletion Mutation in MRP1/ABCC1 and Restores Its Proper Folding and Function

  2017cites this paper
• Technological advances shed light on left ventricular cardiac disturbances in cystic fibrosis.

  2017cites this paper
• Symposium Summaries

  2017cites this paper
• VAMP-associated Proteins (VAP) as Receptors That Couple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Proteostasis with Lipid Homeostasis*

  2016cites this paper
• Long‐range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels

  2016cites this paper
• Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells.

  2016cites this paper
• Biochemical Interrogation of Rare Cystic Fibrosis Mutations Informs Strategies for Future Therapeutic Intervention

  2016cites this paper
• Spatiotemporal Resolution of Rab9 and CI‐MPR Dynamics in the Endocytic Pathway

  2016cites this paper
• Altered membrane lipid raft structure: A potential factor leading to dysregulated neutrophil activity in airways disease.

  2015influential citation
• VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface.

  2014cites this paper
• FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment

  2014cites this paper
• Conserved Allosteric Hot Spots in the Transmembrane Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels and Multidrug Resistance Protein (MRP) Pumps*

  2014cites this paper
• Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis.

  2014cites this paper
• CFTR-mutation specific applications of CFTR-directed monoclonal antibodies.

  2013cites this paper
• Joining the crowd: cystic fibrosis and cardiovascular disease risk factors.

  2013cites this paper
• Regulatory role of β-arrestin-2 in cholesterol processing in cystic fibrosis epithelial cells

  2012cites this paper
• Immunochemical Analysis of Mutant CFTR in Lung Explants

  2012cites this paper
• Functional Rescue of F508del-CFTR Using Small Molecule Correctors

  2012cites this paper
• Urinary secretion and extracellular aggregation of mutant uromodulin isoforms.

  2012cites this paper
• Cationic amphiphilic drug-induced autophagosome accumulation is due to autophagosome sequestration within vimentin intermediate filament networks resulting in prolonged autophagosome half-life

  2012cites this paper
• The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.

  2011cites this paper
• Glycosphingolipid functions.

  2011cites this paper
• AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis

  2011cites this paper
• Defective adenosine‐stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling

  2011cites this paper
• Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis

  2011cites this paper
• Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

  2011cites this paper
• Mechanisms of Altered Cholesterol Metabolism in Cystic Fibrosis

  2011cites this paper
• Effect of Annexin A5 on CFTR: regulated traffic or scaffolding?

  2011cites this paper
• Response in Cystic Fibrosis TLR4 Underlie the Elevated Inflammatory Abnormal Trafficking and Degradation of

  2011cites this paper
• Advances in Pharmacological Treatment of Cystic Fibrosis

  2010cites this paper
• Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures.

  2010cites this paper
• ELECTROCHEMICAL MEASUREMENT OF PLASMA MEMBRANE CHOLESTEROL IN LIVE CELLS AND MOUSE TISSUES

  2010cites this paper
• Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening

  2010cites this paper
• Proinflammatory Phenotype and Increased Caveolin-1 in Alveolar Macrophages with Silenced CFTR mRNA

  2010cites this paper
• Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells

  2009cites this paper
• CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells.

  2009cites this paper
• A soluble sulfogalactosyl ceramide mimic promotes Delta F508 CFTR escape from endoplasmic reticulum associated degradation.

  2009cites this paper
• Novel insights in cholesterol excretion

  2009cites this paper
• Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice.

  2009cites this paper
• Lipid metabolism in cystic fibrosis

  2009cites this paper
• Expression and Distribution of Cystic Fibrosis Transmembrane Conductance Regulator in Neurons of the Human Brain

  2009cites this paper
• Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord

  2009influential citation
• Epithelial ion transport and gastrointestinal fluid homeostasis

  2009cites this paper
• Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles.

  2009cites this paper
• Characterisation of electrogenic nutrient absorption in the CftrTgH(neoim)Hgu mouse model

  2008cites this paper
• Biogenesis, trafficking, and function of wild-type and mutant cystic fibrosis transmembrane conductance regulator (CFTR)

  2008cites this paper
• cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells.

  2008influential citation
• The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function.

  2008cites this paper
• CFTR function and prospects for therapy.

  2008cites this paper
• Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.

  2008cites this paper
• Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport.

  2008cites this paper
• Inhibition of airway proteases in cystic fibrosis lung disease

  2008cites this paper
• Protein interaction and cell surface trafficking differences between wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator

  2007cites this paper
• Fatty acid metabolism in cystic fibrosis.

  2004cites this paper
• Open Access Research

  year unknowncites this paper